The ARIC-PET Amyloid Imaging Study
ARIC-PET 淀粉样蛋白成像研究
基本信息
- 批准号:8162024
- 负责人:
- 金额:$ 59.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-09-15 至 2016-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAgeAgingAlzheimer&aposs DiseaseAmericanAmyloidAmyloid beta-ProteinAmyloid depositionAncillary StudyAtherosclerosisAtrial FibrillationBindingBlood VesselsBrainCerebrovascular DisordersCerebrumClinicalCognitionCognitiveCommunitiesCountryDataDementiaDepositionDevelopmentDiabetes MellitusDiagnosisDiseaseElderlyEpidemiologic StudiesEvaluationFundingFutureGlycosylated hemoglobin AHalf-LifeHemostatic AgentsHyperlipidemiaHypertensionImageImpaired cognitionIn VitroIncidenceIndiumIndividualInfarctionInsulinLabelLife StyleLinkLiteratureMagnetic Resonance ImagingMeasuresMemoryModificationMyocardial InfarctionNeurocognitiveNeurologicObesityOrthostatic HypotensionOutcomeParticipantPathogenesisPathologicPathologyPerformancePeripheral arterial diseasePersonsPittsburgh Compound-BPopulationPositron-Emission TomographyPrevalencePreventionPrevention strategyRecruitment ActivityResearchRetinalRiskRisk FactorsRisk MarkerSenile PlaquesSiteSmokingStrokeSurvivorsTechniquesTestingThickVascular Diseasesagedamyloid imagingcerebrovascularcognitive functioncohortexecutive functionfollow-upheart rate variabilityin vivoinflammatory markerintima mediamiddle agemild neurocognitive impairmentpreventpsychosocialwhite matter
项目摘要
DESCRIPTION (provided by applicant): With the aging of the U.S. population, the importance of developing preventions and treatments for dementia is increasingly apparent. Evidence suggests that certain vascular risk factors like hypertension, smoking and diabetes, especially when they occur in midlife, may contribute to risk for dementia in late life, and possibly even to Alzheimer's dementia (AD), the most common cause of dementia. Thus, addressing the contributing factors related to vascular disease may be an important element in dementia prevention. What is not well understood is whether vascular risk factors actually cause the changes in the brain that cause AD (specifically, ¿-amyloid plaques) or if having both Alzheimer's and vascular changes in the brain together makes the dementia worse. This study will explore these two hypotheses. The ARIC-PET Amyloid Imaging Study is an ancillary study of the Atherosclerosis Risk in Communities (ARIC) study, a large study involving, at its start 25 years ago, 16,000 individuals representative of 4 diverse U.S. communities. In 2011-2013, as part of the currently funded ARIC Neurocognitive (ARIC-NCS) study, the survivors will undergo neurologic evaluation, cognitive assessment, and, in a subset, brain MRI. We will recruit a further subset, 210 individuals aged 70-90 years from Jackson, MS or Hagerstown, MD with either normal cognition or mild cognitive impairment (MCI), to undergo a PET scan with 18F-AV-45, which is a marker used to identify ¿-amyloid in the brain. In the last 2 years of the study, participants will undergo follow-up cognitive evaluation. The study will determine: 1) whether vascular risk factors and markers, especially from midlife, are associated with increased ¿-amyloid binding, which would indicate that vascular disease directly contributes to AD changes in the brain, or 2) whether ¿-amyloid deposits in the brain in combination with vascular risk factors and markers contribute to cognitive impairments and development of dementia. Study results may help optimize future treatment and prevention trials in individuals with mild cognitive impairment who are at risk for dementia. If strong associations are found between vascular disease and ¿-amyloid plaque deposition, this will provide support for aggressive risk factor treatment as a means to decrease cognitive decline and incidence of dementia.
PUBLIC HEALTH RELEVANCE: Millions of Americans have dementia, and Alzheimer's Disease is the most common type of dementia. Understanding the relationship between vascular risk factors and Alzheimer's disease will allow for better preventive strategies of Alzheimer's and other types of dementia, ultimately decreasing the burden of dementia and mild cognitive impairment in this country. !
描述(由申请人提供):随着美国人口的老龄化,开发痴呆症预防和治疗的重要性日益明显。有证据表明,某些血管风险因素,如高血压,吸烟和糖尿病,特别是当它们发生在中年时,可能会导致老年痴呆症的风险,甚至可能导致阿尔茨海默氏痴呆症(AD),这是痴呆症最常见的原因。因此,解决与血管疾病相关的影响因素可能是预防痴呆症的重要因素。目前尚不清楚的是,血管风险因素是否真的会导致大脑中导致AD的变化(特别是淀粉样斑块),或者阿尔茨海默氏症和大脑中的血管变化是否会使痴呆症变得更糟。本研究将探讨这两个假设。ARIC-PET淀粉样蛋白成像研究是社区动脉粥样硬化风险(ARIC)研究的辅助研究,ARIC研究是一项大型研究,25年前开始,涉及代表4个不同美国社区的16,000名个体。在2011-2013年,作为目前资助的ARIC神经认知(ARIC-NCS)研究的一部分,幸存者将接受神经学评估,认知评估,并在一个子集,脑MRI。我们将招募另一个子集,210名来自杰克逊,MS或哈格斯敦,MD的70-90岁的认知正常或轻度认知障碍(MCI)的个体,用18 F-AV-45进行PET扫描,这是一种用于识别大脑中淀粉样蛋白的标记物。在研究的最后2年,参与者将接受随访认知评估。该研究将确定:1)血管风险因素和标志物,特别是中年人的血管风险因素和标志物,是否与增加的淀粉样蛋白结合有关,这表明血管疾病直接导致大脑中的AD变化,或2)大脑中的淀粉样蛋白沉积与血管风险因素和标志物结合是否有助于认知障碍和痴呆的发展。研究结果可能有助于优化未来对有痴呆症风险的轻度认知障碍患者的治疗和预防试验。如果在血管疾病和淀粉样斑块沉积之间发现强相关性,这将为积极的风险因素治疗提供支持,作为降低认知能力下降和痴呆发病率的一种手段。
公共卫生相关性:数百万美国人患有痴呆症,阿尔茨海默病是最常见的痴呆症类型。了解血管危险因素与阿尔茨海默病之间的关系将有助于更好地预防阿尔茨海默病和其他类型的痴呆症,最终减少该国痴呆症和轻度认知障碍的负担。!
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rebecca F Gottesman其他文献
Rebecca F Gottesman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rebecca F Gottesman', 18)}}的其他基金
Neuroepidemiology of the vascular contribution to cognitive impairment and Alzheimer's disease
血管对认知障碍和阿尔茨海默病的影响的神经流行病学
- 批准号:
9323230 - 财政年份:2016
- 资助金额:
$ 59.1万 - 项目类别:
Neuroepidemiology of the vascular contribution to cognitive impairment and Alzheimer's disease
血管对认知障碍和阿尔茨海默病的影响的神经流行病学
- 批准号:
9922187 - 财政年份:2016
- 资助金额:
$ 59.1万 - 项目类别:
Neuroepidemiology of the vascular contribution to cognitive impairment and Alzheimer's disease
血管对认知障碍和阿尔茨海默病的影响的神经流行病学
- 批准号:
9086843 - 财政年份:2016
- 资助金额:
$ 59.1万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The Phenomenon of Stem Cell Aging according to Methylation Estimates of Age After Hematopoietic Stem Cell Transplantation
根据造血干细胞移植后甲基化年龄估算干细胞衰老现象
- 批准号:
23K07844 - 财政年份:2023
- 资助金额:
$ 59.1万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of Age-dependent Functional Changes in Skeletal Muscle CB1 Receptors by an in Vitro Model of Aging-related Muscle Atrophy
通过衰老相关性肌肉萎缩的体外模型分析骨骼肌 CB1 受体的年龄依赖性功能变化
- 批准号:
22KJ2960 - 财政年份:2023
- 资助金额:
$ 59.1万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Joint U.S.-Japan Measures for Aging and Dementia Derived from the Prevention of Age-Related and Noise-induced Hearing Loss
美日针对预防与年龄相关和噪声引起的听力损失而导致的老龄化和痴呆症联合措施
- 批准号:
23KK0156 - 财政年份:2023
- 资助金额:
$ 59.1万 - 项目类别:
Fund for the Promotion of Joint International Research (International Collaborative Research)
The Effects of Muscle Fatigability on Gait Instability in Aging and Age-Related Falls Risk
肌肉疲劳对衰老步态不稳定性和年龄相关跌倒风险的影响
- 批准号:
10677409 - 财政年份:2023
- 资助金额:
$ 59.1万 - 项目类别:
Characterizing gut physiology by age, frailty, and sex: assessing the role of the aging gut in "inflamm-aging"
按年龄、虚弱和性别表征肠道生理学特征:评估衰老肠道在“炎症衰老”中的作用
- 批准号:
497927 - 财政年份:2023
- 资助金额:
$ 59.1万 - 项目类别:
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
- 批准号:
10679287 - 财政年份:2023
- 资助金额:
$ 59.1万 - 项目类别:
Role of AGE/RAGEsignaling as a driver of pathological aging in the brain
AGE/RAGE信号传导作为大脑病理性衰老驱动因素的作用
- 批准号:
10836835 - 财政年份:2023
- 资助金额:
$ 59.1万 - 项目类别:
Elucidation of the protein kinase NLK-mediated aging mechanisms and treatment of age-related diseases
阐明蛋白激酶NLK介导的衰老机制及年龄相关疾病的治疗
- 批准号:
23K06378 - 财政年份:2023
- 资助金额:
$ 59.1万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Underlying mechanisms of age-related changes in ingestive behaviors: From the perspective of the aging brain and deterioration of the gustatory system.
与年龄相关的摄入行为变化的潜在机制:从大脑老化和味觉系统退化的角度来看。
- 批准号:
23K10845 - 财政年份:2023
- 资助金额:
$ 59.1万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Targeting Age-Activated Proinflammatory Chemokine Signaling by CCL2/11 to Enhance Skeletal Muscle Regeneration in Aging
通过 CCL2/11 靶向年龄激活的促炎趋化因子信号传导以增强衰老过程中的骨骼肌再生
- 批准号:
478877 - 财政年份:2023
- 资助金额:
$ 59.1万 - 项目类别:
Operating Grants